Breast Cancer Clinical Trial

Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk

Summary

The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.

View Full Description

Full Description

We examined a low carbohydrate diet (40% carbohydrates, 30% protein, 30% fat) versus a low fat diet (60% carbohydrates, 20% protein, 20% fat) to determine the impact of these dietary patterns, combined with exercise, on weight loss, body shape and body composition.

Inclusion Criteria:

Aged 30 and older
Premenopausal (may be confirmed by FSH)
No previous diagnosis of cancer (except non-melanomatous skin cancer)
Body mass index between 25-34 kg/m2
Women must be expected to live in the Columbus area for the next 18 months
All women must present a letter of medical clearance from their primary care physician

Exclusion Criteria:

Pregnant women or women who plan to become pregnant during the study period will not be enrolled. Women who become pregnant during the intervention will be withdrawn from the study.
Women who are already participating in a formal weight loss program (such as Weight Watchers) will not be eligible.
Women with a medical history that precludes adherence to either of the two dietary patterns will also be excluded. This includes a history of renal insufficiency, gluten enteropathy, Crohn's disease or other medical conditions that significantly impact nutritional status or metabolism. Women with either type I or controlled type II diabetes will be eligible to participate in this trial.
All medical problems must be managed and controlled. Lipid profile, blood glucose, hemoglobin A1c, and blood pressure will be assessed at the screening visit. These results will be reviewed by the study physician. Women who have abnormal values that, at the discretion of the study physician, would benefit from medical management will be referred to a primary care physician prior to considering them for enrollment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Aged 30 and older
Premenopausal (may be confirmed by FSH)
No previous diagnosis of cancer (except non-melanomatous skin cancer)
Body mass index between 25-34 kg/m2
Women must be expected to live in the Columbus area for the next 18 months.
All women must present a letter of medical clearance from their primary care physician.

Exclusion Criteria:

Pregnant women or women who plan to become pregnant during the study period will not be enrolled. Women who become pregnant during the intervention will be withdrawn from the study.
Women who are already participating in a formal weight loss program (such as Weight Watchers)will not be eligible.
Women with a medical history that precludes adherence to either of the two dietary patterns will also be excluded. This includes a history of renal insufficiency, gluten enteropathy, Crohn's disease or other medical conditions that significantly impact nutritional status or metabolism. Women with either type I or controlled type II diabetes will be eligible to participate in this trial.
All medical problems must be managed and controlled. Lipid profile, blood glucose, hemoglobin A1c, and blood pressure will be assessed at the screening visit. These results will be reviewed by the study physician. Women who have abnormal values that, at the discretion of the study physician, would benefit from medical management will be referred to a primary care physician prior to considering them for enrollment.

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

82

Study ID:

NCT01559194

Recruitment Status:

Completed

Sponsor:

Ohio State University Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Ohio State University
Columbus Ohio, 43201, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

82

Study ID:

NCT01559194

Recruitment Status:

Completed

Sponsor:


Ohio State University Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider